◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocksCVS › Operating Income

CVS Health Corp (CVS) Operating Income 2006–TTM

DATA UPDATED 2026-07-12

CVS Health Corp annual operating income for fiscal TTM was $6.0 billion, a decrease of 42.6% from $10.4 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

CVS Annual Operating Income

Operating Income (annual)TTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Operating Income (EBIT)$6.0B$10.4B$8.5B$13.7B$8.0B$13.3B$13.9B$12.0B$4.0B$9.5B$10.4B$9.5B$8.8B$8.0B$7.2B$6.3B$6.1B$6.4B$6.0B$4.8B$2.4B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CVS Quarterly Operating Income

Operating Income (quarterly)2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Operating Income (EBIT)$4.7B$2.1B($3.2B)$2.4B$3.4B$2.4B$832M$3.0B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More CVS metrics: Revenue · Gross Profit · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All CVS financial statements → Interactive CVS charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.